Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

J Immunother Cancer · 2025 · PMC12506175 · PMID 41052886

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Manual assessment of CD8/mm2 showed a trend association with ML-based ICI/mm2 counts, highlighting how T-cell polarisation contributes to ICI but does not exclusively nor univocally define it.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.